PROSPECTIVE OBSERVATIONAL STUDY IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS TREATED WITH LANREOTIDE DEPOT IN A US COMMUNITY ONCOLOGY SETTING – IPSEN A-US-52030-340, NCT02730104
PURPOSE OF THIS CLINICAL RESEARCH TRIAL
The purpose of this trial is to assess time to disease progression of patients with locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors treated with Lanreotide Depot. This is an observational study therefore all data collected will be in accordance with the routine practice of physicians.
MORE DETAILS ON THIS TRIAL
15051 / NCT02730104